1h Free Analyst Time
The hiv treatment drugs market in africa is forecasted to grow by USD 280.2 million during 2023-2028, accelerating at a CAGR of 3.2% during the forecast period. The report on the hiv treatment drugs market in africa provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of stds, favorable international programs, and government collaborations.
The hiv treatment drugs market in africa is segmented as below:
By Drug Class
- Reverse transcriptase inhibitors
- Protease inhibitors
- Integrase inhibitors
- Fusion inhibitors
- Coreceptor antagonists
By Route Of Administration
- Oral drugs
- Injectable drugs
By Geographical Landscape
- Africa
The report on the hiv treatment drugs market in africa covers the following areas:
- Hiv treatment drugs market in africa sizing
- Hiv treatment drugs market in africa forecast
- Hiv treatment drugs market in africa industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Drug Class
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the HIV treatment drugs market in Africa: Abbott Laboratories, AbbVie Inc., Alpha Pharma, Aspen Pharmacare Holdings Ltd., AstraZeneca PLC, Aurobindo Pharma Ltd., Avacare Health, Boehringer Ingelheim International GmbH, Cipla Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Hetero Labs Ltd., Johnson and Johnson Services Inc., Merck and Co. Inc., SSI Diagnostica AS, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Theratechnologies Inc., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in awareness by various organizations."
According to the report, one of the major drivers for this market is the increasing prevalence of stds.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AbbVie Inc.
- Alpha Pharma
- Aspen Pharmacare Holdings Ltd.
- AstraZeneca Plc
- Aurobindo Pharma Ltd.
- Avacare Health
- Boehringer Ingelheim International GmbH
- Cipla Inc.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Hetero Labs Ltd.
- Johnson and Johnson Services Inc.
- Merck and Co. Inc.
- SSI Diagnostica AS
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Theratechnologies Inc.
- Viatris Inc.
